NeurosciencebioRxivPreprint
Targeting the ClpP-αSynuclein Interaction with a Decoy Peptide to Mitigate Neuropathology in Parkinson's Disease Models
This study develops a decoy peptide, CS2, that disrupts the ClpP-αSynuclein interaction, reducing neuropathology in Parkinson's disease models.
1 citation